India to Mauritius: Linagliptin Export Trade Route

The India to Mauritius Linagliptin corridor is one of India's established pharmaceutical export routes, with 130 shipments documented worth a combined $149.6K USD. The route is dominated by HEXA HEALTHCARE PVT LTD, which alone accounts for roughly 23% of all export value, reflecting the consolidated nature of India's linagliptin manufacturing sector.

Across 12 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 30.9%, placing it at rank #16 among India's top linagliptin export destinations globally.

On the import side, key buyers of Indian linagliptin in Mauritius include REGENCY PHARMA LIMITED, HYPERPHARM LIMITED, ZAPATERO INTERNATIONAL LTD and 7 others. REGENCY PHARMA LIMITED is the single largest importer with 70 shipments valued at $71.9K USD.

India's linagliptin exports to Mauritius are driven primarily by a handful of large-scale manufacturers. HEXA HEALTHCARE PVT LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Mauritius benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HEXA HEALTHCARE PVT LTD, SAVA HEALTHCARE LIMITED, PLEASANT EXPORTS — together account for 63% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma.ingredient of ind.originpharma.finished formulation for pharma.industry-lina nish 2.5/1000 linagliptin 2.5mg & and trajenta 5mg 90 tab linagliptin , suggesting that buyers in Mauritius tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, REGENCY PHARMA LIMITED is the largest importer with 70 shipments worth $71.9K USD — representing 48% of all linagliptin imports from India on this route. A total of 10 buyers are active on this corridor.